Doctors are increasingly noticing a troubling trend: more young people under the age of 50 are being diagnosed with ...

Despite a continuous decline in the rate of breast cancer deaths in the United States, the incidence of the disease has ...

About 40 percent of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...

Death rates are declining among U.S. women with breast cancer. But the disease is turning up more often in women under age 50 ...

Americans have benefited from huge leaps in breast cancer treatment over the last two decades, but diagnoses are becoming ...

Blue Cross Blue Shield of Massachusetts ("Blue Cross") wants to ensure that members know their options for colorectal cancer screening. The United States Preventive Services Task Force (USPSTF) ...

Recent advancements in cancer detection shows five key blood tests that can identify cancer early, improving treatment ...

Savita Dandapani, MD, PhD, discussed combining radium-223 and SBRT for metastatic castration-sensitive prostate cancer.

Immune checkpoint inhibitors industry is projected to witness a CAGR of 16.7% during the period 2024-2032. This growth can be ...

Join us on for a thought-provoking evening with pre-eminent artist Shahzia Sikander in conversation with Dhaka art summit curator Diana Campbell, reflecting on the evolution and art-historical ...

It is the first of a slew of cancer drugs to now funded by Pharmac following the agency's multi-million dollar budget boost.

According to DelveInsight’s analysis, the growth of the KRAS Inhibitors market is expected to be mainly driven by increasing incidence, a rise in awareness and access to treatment, and robust pipeline ...